Insider · CIK 0001711462
Paul F. Lizzul
officer
Files at ANAB (ANAPTYSBIO, INC). First filing Dec 23, 2025, latest Jan 9, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $522k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ANAB: ANAPTYSBIO, INC
ANABOct 9, 2026 · close 45.95
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | ANAPTYSBIO, INC | $163k 3,650 shares | -8% | +254% from low-14% from high | |
| 25Weak | ANAPTYSBIO, INC | $101k 2,235 shares | -6% | +265% from low-11% from high | |
| 32Weak | ANAPTYSBIO, INC | $183k 4,219 shares | -11% | +249% from low-15% from high | |
| 3Weak | ANAPTYSBIO, INC | $75k 1,500 shares | -5% | +307% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +8,525 | - | - | 45,738 | Jan 9, 2026 |
| Jan 8, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock | -3,650 | $44.71 | $163k | 42,088 | Jan 9, 2026 |
| Jan 7, 2026 | ANAB ANAPTYSBIO, INC | MOption exercise Restricted Stock Unitderivative | -8,525 | $0.00 | $0 | 25,575 | Jan 9, 2026 |
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +6,145 | - | - | 39,448 | Jan 8, 2026 |
| Jan 7, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock | -2,235 | $45.11 | $101k | 37,213 | Jan 8, 2026 |
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | MOption exercise Restricted Stock Unitderivative | -6,145 | $0.00 | $0 | 6,145 | Jan 8, 2026 |
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | AGrant or award Restricted Stock Unitderivative | +21,400 | $0.00 | $0 | 21,400 | Jan 8, 2026 |
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | AGrant or award Stock Option (right to buy)derivative | +29,000 | $0.00 | $0 | 29,000 | Jan 8, 2026 |
| Jan 3, 2026 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +10,555 | - | - | 37,522 | Jan 6, 2026 |
| Jan 5, 2026 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock | -4,219 | $43.26 | $183k | 33,303 | Jan 6, 2026 |
| Jan 3, 2026 | ANAB ANAPTYSBIO, INC | MOption exercise Restricted Stock Unitderivative | -10,555 | $0.00 | $0 | 21,110 | Jan 6, 2026 |
| Dec 22, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock10b5-1 | +1,500 | $18.50 | $28k | 28,467 | Dec 23, 2025 |
| Dec 22, 2025 | ANAB ANAPTYSBIO, INC | SOpen-market sale Common Stock10b5-1 | -1,500 | $50.00 | $75k | 26,967 | Dec 23, 2025 |
| Dec 22, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -1,500 | $0.00 | $0 | 83,500 | Dec 23, 2025 |
| Jan 3, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +10,555 | - | - | 26,095 | Jan 7, 2025 |
| Jan 3, 2025 | ANAB ANAPTYSBIO, INC | FTax withholding Common Stock | -4,336 | $14.60 | $63k | 21,759 | Jan 7, 2025 |
| Jan 6, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +6,145 | - | - | 27,904 | Jan 7, 2025 |
| Jan 6, 2025 | ANAB ANAPTYSBIO, INC | FTax withholding Common Stock | -2,261 | $15.30 | $35k | 25,643 | Jan 7, 2025 |
| Jan 3, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Restricted Stock Unitderivative | -10,555 | $0.00 | $0 | 31,665 | Jan 7, 2025 |
| Jan 6, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Restricted Stock Unitderivative | -6,145 | $0.00 | $0 | 12,290 | Jan 7, 2025 |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | AGrant or award Restricted Stock Unitderivative | +34,100 | $0.00 | $0 | 34,100 | Jan 7, 2025 |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | AGrant or award Stock Option (right to buy)derivative | +97,200 | $0.00 | $0 | 97,200 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.